Directors intent re subscription rights

Summary by AI ^BETAClose X

Geiger Counter Limited announced that its Chairman, Gary Clark, and Non-Executive Director, James Leahy, intend to subscribe for new ordinary shares. Gary Clark will subscribe for 50,020 shares for £18,607, increasing his total holding to 250,102 shares, while James Leahy will subscribe for 22,838 shares for £8,496, bringing his total to 114,194 shares. In total, directors are subscribing for 72,858 shares for £27,103, and the terms are considered fair and reasonable for shareholders.

Disclaimer*

Geiger Counter Ltd

16 April 2026

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED

Geiger Counter Limited (or the "Company")

16 April 2026

Director Subscriptions

Further to the announcement by the Company on 30 March 2026, in respect of the right to subscribe for Ordinary Shares in the Company, the following directors intend to exercise their subscription rights in respect of their shareholdings as follows:

Director	Position	Total Ordinary Shares held	Subscription Shares intended to subscribe for	Amount (£)
Gary Clark	Chairman	250,102	50,020	18,607
James Leahy	Non Executive Director	114,194	22,838	8,496
Total		364,296	72,858	27,103

The Directors consider that the terms of the Director's subscriptions are fair and reasonable insofar as shareholders are concerned.

Enquiries

Manulife \| CQS Investment Management	Craig Cleland	T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited	Tunga Chigovanyika (Corporate Finance)	T: +44 (0) 20 7397 1915
	Daniel Balabanoff / Pauline Tribe (Sales)	T: +44 (0) 20 7220 0500
Summit Fund Services Jersey Limited	Christopher Foulds	T:+44 (0) 1534 825 259

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END